Lipid tucaresol as an adjuvant for methamphetamine vaccine development.
about
Impact of methamphetamine on infection and immunityDesign, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresolConjugate Vaccine Immunotherapy for Substance Use Disorder.Biologics to treat substance use disorders: Current status and new directionsMethamphetamine Vaccines: Improvement through Hapten Design.Current status and future prospects for the development of substance abuse vaccines.
P2860
Lipid tucaresol as an adjuvant for methamphetamine vaccine development.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Lipid tucaresol as an adjuvant for methamphetamine vaccine development.
@ast
Lipid tucaresol as an adjuvant for methamphetamine vaccine development.
@en
type
label
Lipid tucaresol as an adjuvant for methamphetamine vaccine development.
@ast
Lipid tucaresol as an adjuvant for methamphetamine vaccine development.
@en
prefLabel
Lipid tucaresol as an adjuvant for methamphetamine vaccine development.
@ast
Lipid tucaresol as an adjuvant for methamphetamine vaccine development.
@en
P2093
P2860
P356
P1476
Lipid tucaresol as an adjuvant for methamphetamine vaccine development.
@en
P2093
J E Schlosburg
J W Lockner
K C Collins
P T Bremer
P2860
P304
P356
10.1039/C4CC00682H
P407
P577
2014-04-01T00:00:00Z